aod9604 clinical trials obesity Understanding AOD 9604: The Science of the “Fat-Burning” Peptide Fragment AOD-9604 – 10 Mg –

SAM was obtained from Sigma Aldrich and nicotinamide from Fluka Analytical (Kwazulu Natal, South Africa

The most common AEs reported during the study were: Headache (6 times) Fatigue (4) Hypoglycemia unspecified (3) Dizziness (3) Nasopharyngitis (2) Cough (2) Lethargy (1) Tonsillitis (1) Abdominal pain unspecified (1) Application site reaction unspecified (1) Injection site bruising (1) Rhinitis seasonal (1) Anorexia (1) Injection site pain (1) None of the AEs were of severe intensity and there was no observable trend between the different treatment groups with respect to the incidence of certain AEs

You have a right to know exactly what is being injected into your body

For many patients today this frequency however, would be a miracle

Ipamorelin for beginners: Dosage, benefits, and how to stack (2025)